Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) EPS (Basic): 2011-2025

Historic EPS (Basic) for Abeona Therapeutics (ABEO) over the last 14 years, with Sep 2025 value amounting to -$0.10.

  • Abeona Therapeutics' EPS (Basic) rose 84.13% to -$0.10 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.59, marking a year-over-year increase of 170.98%. This contributed to the annual value of -$1.55 for FY2024, which is 38.74% up from last year.
  • Per Abeona Therapeutics' latest filing, its EPS (Basic) stood at -$0.10 for Q3 2025, which was down 104.83% from $2.07 recorded in Q2 2025.
  • Abeona Therapeutics' 5-year EPS (Basic) high stood at $2.07 for Q2 2025, and its period low was -$11.64 during Q4 2021.
  • Over the past 3 years, Abeona Therapeutics' median EPS (Basic) value was -$0.48 (recorded in 2023), while the average stood at -$0.24.
  • Per our database at Business Quant, Abeona Therapeutics' EPS (Basic) plummeted by 6,747.06% in 2021 and then soared by 989.47% in 2025.
  • Quarterly analysis of 5 years shows Abeona Therapeutics' EPS (Basic) stood at -$11.64 in 2021, then spiked by 104.47% to $0.52 in 2022, then slumped by 223.08% to -$0.64 in 2023, then surged by 78.12% to -$0.14 in 2024, then skyrocketed by 84.13% to -$0.10 in 2025.
  • Its last three reported values are -$0.10 in Q3 2025, $2.07 for Q2 2025, and -$0.24 during Q1 2025.